Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. KORU Medical Systems's retained earnings for the quarter that ended in Jun. 2026 was $-32.57 Mil.
KORU Medical Systems's quarterly retained earnings
declined
from Dec. 2025 ($-32.02 Mil) to Mar. 2026 ($-32.82 Mil) but then
increased
from Mar. 2026 ($-32.82 Mil) to Jun. 2026 ($-32.57 Mil).
KORU Medical Systems's annual retained earnings
declined
from Dec. 2023 ($-23.31 Mil) to Dec. 2024 ($-29.38 Mil) and
declined
from Dec. 2024 ($-29.38 Mil) to Dec. 2025 ($-32.02 Mil).
KORU Medical Systems (NAS:KRMD) Retained Earnings Explanation
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
KORU Medical Systems Retained Earnings Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KORU Medical Systems Retained Earnings Calculation
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
What does a Retained Earnings of $-32.57 Mil mean?
KORU Medical Systems (KRMD) has a Retained Earnings of $-32.57 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on KORU Medical Systems and its competitors.
Is KORU Medical Systems' Retained Earnings too high?
KORU Medical Systems' current Retained Earnings is $-32.57 Mil. Overall, KORU Medical Systems has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Retained Earnings compare to PDEX and EMBC?
KORU Medical Systems' Retained Earnings of $-32.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on KORU Medical Systems and its competitors. KORU Medical Systems's current Retained Earnings is $-32.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.01, compared to a current price of $3.39 — trading 15.5% below its estimated fair value. The current Retained Earnings is $-32.57 Mil. KORU Medical Systems' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Retained Earnings is $-32.57 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be undervalued.
The current stock price of $3.39 is trading 15.5% below its estimated GF Value™ of $4.01.
GuruFocus considers KORU Medical Systems to be Modestly Undervalued.
Key valuation signals for KRMD:
Retained Earnings: $-32.57 Mil
GF Value™: $4.01 vs. price of $3.39 (15.5% below fair value)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
80GF Score
Get the complete analysis for KRMD
Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
